Latest News and Press Releases
Want to stay updated on the latest news?
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} KØBENHAVN, Danmark, 22. november 2017 -...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COPENHAGEN, Denmark, November 22, 2017 -...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Pressmeddelande 22 november 2017...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release November 22, 2017...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ...
-
SYDNEY, Australia, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”, the “Company”) announces the grant of patent number 2604275 entitled “Use of Recombinant LAG-3...
-
Mijlpaalbetaling van $10 miljoen van AbbVieZesde klinisch kandidaatmedicijn in cystic fibrosis portfolio Mechelen, België; 21 november 2017; 22.01 CET - Galapagos NV (Euronext & NASDAQ: GLPG)...
-
Triggers a $10 million milestone payment from AbbVieSixth clinical candidate in cystic fibrosis portfolio Mechelen, Belgium; 21 November 2017; 22.01 CET -Galapagos NV (Euronext & NASDAQ: GLPG)...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Option på ca. USD 37 mio. vil understøtte det...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Award of approximately USD 37 million...